Skip to main content

Day: May 20, 2021

Centerra Gold Announces Proceedings Against Former Board Director Tengiz Bolturuk

Identifies Attempted Fraud by Kyrgyzaltyn JSC and Responds to Inaccurate Statements by Bolturuk and Kyrgyz Officials TORONTO, May 20, 2021 (GLOBE NEWSWIRE) — Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) today announced that it had initiated proceedings in the Ontario Superior Court of Justice against Tengiz Bolturuk, a former member of its Board of Directors, in response to flagrant breaches of his fiduciary duties to the Company related to the recent seizure of the Kumtor Mine by the Government of the Kyrgyz Republic. Centerra seeks to enjoin Mr. Bolturuk, who was nominated to the Board by the Kyrgyz state-owned entity and Centerra shareholder Kyrgyzaltyn JSC, from direct or indirect involvement in the management of the Kumtor Mine as well as engaging in further breaches of fiduciary and confidentiality...

Continue reading

Ikonart® and Teresa Collins Announce Brand Collaboration to Accelerate Product Growth & Distribution

DULUTH, Minn., May 20, 2021 (GLOBE NEWSWIRE) — IKONICS Corporation. (NASDAQ: IKNX), a Duluth, Minnesota based imaging technology company and leading global manufacturer of photochemistry products announced they will work together with Teresa Collins Studio, a worldwide brand in the creative crafts market. The companies agree to collaborate in the promotion of the Ikonart® Custom Stencil Kit along with the Ikonart ancillary product line, leading to creative resources for crafters in the worldwide art supplies industry. Ikonart intends to use Teresa Collins’ brand images, designs, prints and patterns to help both companies integrate further into larger distribution channels. “Our line of Ikonart stencil films are the only customizable adhesive silkscreen stencil films on the market,” stated Fawn Giese, Creative Director for Ikonart....

Continue reading

Dream Industrial REIT Announces $250 Million Subscription Receipt Offering in Connection With Proposed European Logistics Acquisition

This press release constitutes a “designated news release” for the purposes of Dream Industrial REIT’s prospectus supplement dated February 26, 2021 to its short form base shelf prospectus dated October 11, 2019 This press release contains forward-looking information that is based upon assumptions and is subject to risks and uncertainties as indicated in the cautionary note contained within this press release. NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES HighlightsExclusive and advanced discussions on a portfolio of 31 institutional quality, logistics properties in strong European industrial markets Real estate is valued at approximately €880 million ($1.3 billion1) which implies an expected going in capitalization rate in the low 4% range, including excess land with approximately 1.1 million...

Continue reading

Prospect Capital Corporation Announces Pricing of $300 Million of 3.364% Notes due 2026

NEW YORK, May 20, 2021 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) announced today the pricing of $300 million in aggregate principal amount of 3.364% notes due 2026 (the “Notes”). The Notes will mature on November 15, 2026 and may be redeemed in whole or in part at any time or from time to time at our option at par plus a “make-whole” premium, if applicable. The Notes will bear interest at a rate of 3.364% per year payable semi-annually in arrears on May 15 and November 15 of each year, commencing on November 15, 2021. The Notes will be general senior unsecured obligations of Prospect, will rank equally in right of payment with Prospect’s existing and future senior unsecured debt, and will rank senior in right of payment to any potential subordinated debt, should any be issued...

Continue reading

Larimar Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for CTI-1601 in Friedreich’s Ataxia

BALA CYNWYD, Pa., May 20, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for Friedreich’s ataxia (FA) and other complex rare diseases, today announced that the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to CTI-1601 for the treatment of FA. CTI-1601 is a recombinant fusion protein intended to deliver human frataxin into the mitochondria of patients with FA who are unable to produce enough of this essential protein. The PRIME designation was based on positive data from Larimar’s nonclinical studies and Phase 1 clinical program in patients with FA. As announced last week, pharmacodynamic data from this program showed that daily subcutaneous injections of CTI-1601 at doses of 50 mg or 100 mg...

Continue reading

Ares Management Corporation Announces Agreement to Acquire Black Creek Group

Leading Core / Core-Plus Real Estate Firm Will Expand Ares’ Real Estate Group with Complementary Capabilities and Vertically Integrated Platform in High Conviction Industrial Sector   Business Combination Will Add Significant Perpetual, Non-Traded REIT Capital and Retail Distribution Platform with Capacity to Scale Existing and New Products Combined Real Estate Group Assets Under Management to Increase to Approximately $29 Billion LOS ANGELES, May 20, 2021 (GLOBE NEWSWIRE) — Ares Management Corporation (“Ares”) (NYSE: ARES) announced today that a subsidiary of Ares has entered into a definitive agreement to acquire 100% of Black Creek Group’s U.S. real estate investment advisory and distribution business (“Black Creek”), a leading real estate investment management firm. Founded in 1993, Black Creek had approximately $11.6 billion...

Continue reading

Hawkins, Inc. Declares Quarterly Cash Dividend of $0.1225 Per Share

Roseville, Minn., May 20, 2021 (GLOBE NEWSWIRE) — The Board of Directors of Hawkins, Inc. (Nasdaq: HWKN), at its meeting on May 20, 2021, declared a quarterly cash dividend of $0.1225 per share payable June 18, 2021, to shareholders of record at the close of business on June 4, 2021.   Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading specialty chemical company that distributes, blends and manufactures chemicals and other specialty ingredients for its Industrial, Water Treatment, and Health & Nutrition customers.  Headquartered in Roseville, Minnesota, and with 46 facilities in 22 states, the Company creates value for its customers through superb customer service and support, quality products and personalized applications.  Hawkins, Inc. generated...

Continue reading

Navient declares second quarter common stock dividend

WILMINGTON, Del., May 20, 2021 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI), a leader in education loan management and business processing solutions, announced that its board of directors approved a 2021 second quarter dividend of $0.16 per share on the company’s common stock. The second quarter 2021 dividend will be paid on June 18, 2021, to shareholders of record at the close of business on June 4, 2021. About NavientNavient (Nasdaq: NAVI) is a leading provider of education loan management and business processing solutions for education, healthcare, and government clients at the federal, state, and local levels. Navient helps clients and millions of Americans achieve success through technology-enabled financing, services, and support. Learn more at Navient.com. Contact:Media: Paul Hartwick, 302-283-4026, paul.hartwick@navient.com Investors:...

Continue reading

SeaSpine Announces Closing of 7D Surgical Acquisition

CARLSBAD, Calif., May 20, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the previously announced acquisition of 7D Surgical. 7D Surgical is a Toronto-based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care. 7D Surgical’s flagship FLASH™ Navigation System delivers significant improvement to surgical workflows in spine and cranial surgeries. The underlying technology provides the opportunity for similar advancements in other surgical specialties. “We are truly excited to welcome the 7D Surgical team and their market-leading Flash Navigation technology to the SeaSpine...

Continue reading

Orezone Provides an Update on the Project Debt Package

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 20, 2021 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX.V: ORE OTCQX: ORZCF) (the “Company”) announces that the Project Debt Package is progressing well and the Company is working to finalize documentation on the Senior Debt Facility, the Convertible Note Facility, the Silver Stream Agreement and the related intercreditor agreement. As required by the policies of the TSX Venture Exchange, the Company is issuing this press release as part of the application to the TSXV with respect to the Convertible Note Facility. The 8.5% Convertible Note Facility included in the Project Debt package will be convertible at the option of the lenders at any time at a conversion price of US$1.08 (the “Conversion Price”), representing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.